Grants per year
Personal profile
Training Experience
| 1996 | Internship, Stony Brook University Medical Center |
| 1996 | Residency, Stony Brook University Medical Center |
| 2002 | Fellowship, University of California, Los Angeles |
Education/Academic qualification
Medicine, MD, Carol Davila University of Medicine and Pharmacy
… → 1992
Fingerprint
Dive into the research topics where Daniela Elena Matei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
VA IPA - Yinu Wang 2023-2024
Matei, D. E. (PD/PI), Wang, Y. (Other) & Wang, Y. (Other)
11/28/23 → 9/30/25
Project: Research project
-
Targeting Tissue Transglutaminase to Enhance Antitumor Immunity in Ovarian Cancer
Matei, D. E. (PD/PI) & Kocherginsky, M. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
9/1/23 → 8/31/26
Project: Research project
-
Targeting Pyrimidine Synthesis to Overcome Resistance to Platinum in Ovarian Cancer
Matei, D. E. (PD/PI), Matei, D. E. (PD/PI), Matei, D. E. (PD/PI), Huang, H. (Other), Huang, H. (Other) & Huang, H. (Other)
Ovarian Cancer Alliance of Greater Cincinnati
7/28/23 → 7/27/25
Project: Research project
-
Prot #ACR-368-201/GOG-3082: A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSign
Matei, D. E. (PD/PI)
Gynecologic Oncology Group, Acrivon Therapeutics, Inc
3/24/23 → 3/24/26
Project: Research project
-
Biology-driven therapy advances in high-grade serous ovarian cancer
Wang, Y., Duval, A. J., Adli, M. & Matei, D., Jan 20 2024, In: Journal of Clinical Investigation. 134, 1, e174013.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells
Valdivia, A., Cowan, M., Cardenas, H., Isac, A. M., Zhao, G., Huang, H. & Matei, D., 2024, In: Frontiers in Oncology. 14, 1304691.Research output: Contribution to journal › Article › peer-review
Open Access -
Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance
Wang, Y., Calvert, A. E., Cardenas, H., Rink, J. S., Nahotko, D., Qiang, W., Ndukwe, C. E., Chen, F., Keathley, R., Zhang, Y., Cheng, J. X., Thaxton, C. S. & Matei, D., Apr 3 2024, In: Advanced Science. 11, 13, 2305212.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
Wang, Y., Situ, X., Cardenas, H., Siu, E., Alhunayan, S. A., Keathley, R., Tanner, E. J., Wei, J. J., Tan, Y., Dessai, C. V. P., Cheng, J. X. & Matei, D., Mar 15 2024, In: Clinical Cancer Research. 30, 6, p. 1175-1188 14 p.Research output: Contribution to journal › Article › peer-review
-
Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)
Valdivia, A., Vagadia, P. P., Guo, G., O’Brien, E., Matei, D. & Schiltz, G. E., Jul 27 2023, In: Journal of Medicinal Chemistry. 66, 14, p. 9445-9465 21 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Datasets
-
Methylomic Signatures of High Grade Serous Ovarian Cancer
Cardenas, H. (Creator), Fang, F. (Creator), Jiang, G. (Creator), Perkins, S. M. (Creator), Zhang, C. (Creator), Emerson, R. E. (Creator), Hutchins, G. (Creator), Keer, H. N. (Creator), Liu, Y. (Creator), Matei, D. (Creator) & Nephew, K. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.13348082.v1, https://tandf.figshare.com/articles/dataset/Methylomic_Signatures_of_High_Grade_Serous_Ovarian_Cancer/13348082/1
Dataset